Effects of placebos without deception compared with no treatment: A systematic review and meta-analysis

Journal of Evidence-Based Medicine

Volumn 10, Issue 2, 2017, Pages 97-107

  Charlesworth, James E G ^a   Petkovic, Grace ^a   Kelley, John M ^b,c   Hunter, Monika ^d   Onakpoya, Igho ^a   Roberts, Nia ^e   Miller, Franklin G ^f   Howick, Jeremy ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ENDICOTT COLLEGE   (United States)

^d CANTERBURY CHRIST CHURCH UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

ethics; expectation; nondeceptive; placebo; suggestion

Indexed keywords

PLACEBO;

ALLERGIC RHINITIS; ARTICLE; ATTENTION DEFICIT DISORDER; BACKACHE; CLINICAL EFFECTIVENESS; DECEPTION; DEPRESSION; HUMAN; IRRITABLE COLON; META ANALYSIS; PLACEBO EFFECT; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; WATCHFUL WAITING;

DECEPTION; HUMANS; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WATCHFUL WAITING;

EID: 85020027683     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/jebm.12251     Document Type: Article

References (40)

1. Fässler M, Meissner K, Schneider A, et al. Frequency and circumstances of placebo use in clinical practice—a systematic review of empirical studies. BMC Med. 2010;8:15.
2. Howick J, Bishop FL, Heneghan C, et al. Placebo use in the United Kingdom: results from a national survey of primary care practitioners. PLoS One. 2013;8:e58247.
3. Beecher HK. The powerful placebo. J Am Med Assoc. 1955;159:1602–1606.
4. Kienle GS, Kiene H. The powerful placebo effect: fact or fiction? J Clin Epidemiol. 1997;50:1311–1318.
5. Hróbjartsson A, Gøtzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev. 2010;CD003974.
6. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344:1594–1602.
7. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med. 2004;256:91–100.
8. General Medical Council (Great Britain). Good medical practice. 2013. http://www.gmc-uk.org/static/documents/content/GMP_.pdf
9. Bostick NA, Sade R, Levine MA, et al. Placebo use in clinical practice: report of the American Medical Association Council on Ethical and Judicial Affairs. J Clin Ethics. 2008;19:58–61.
10. Aulas JJ, Rosner I. [Efficacy of a non blind placebo prescription]. Encephale. 2003;29:68–71.
11. Kaptchuk TJ, Friedlander E, Kelley JM, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One. 2010;5:e15591.
12. Park LC, Covi L. Nonblind placebo trial: an exploration of neurotic patients’ responses to placebo when its inert content is disclosed. Arch Gen Psychiatry. 1965;12:36–45.
13. Sandler AD, Bodfish JW. Open-label use of placebos in the treatment of ADHD: a pilot study. Child. 2008;34:104–110.
14. Rothwell PM, ed. The Lancet: Treating Individuals: From Randomised Trials to Personalised Medicine. Edinburgh; New York: Elsevier; 2007.
15. Kelley JM, Kaptchuk TJ, Cusin C, et al. Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychother Psychosom. 2012;81:312–314.
16. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org.
17. Walach H, Schmidt S, Bihr Y-M, et al. The effects of a caffeine placebo and experimenter expectation on blood pressure, heart rate, well-being, and cognitive performance. Eur Psychol. 2001;6:15–25.
18. Walach H, Schmidt S, Dirhold T, et al. The effects of a caffeine placebo and suggestion on blood pressure, heart rate, well-being and cognitive performance. Int J Psychophysiol. 2002;43:247–260.
19. Urroz P. Effect of acupuncture and instruction on post-exercise recovery: a balanced-placebo controlled trial. Master of Science Thesis (School of Science and Health, University of Western Sydney) 2014.
20. Schneider R, Grüner M, Heiland A, et al. Effects of expectation and caffeine on arousal, well-being, and reaction time. Int J Behav Med. 2006;13:330–339.
21. Petkovic G, Charlesworth JEG, Kelley J, et al. Effects of placebos without deception compared with no treatment: protocol for a systematic review and meta-analysis. BMJ Open. 2015;5:e009428.
22. Schaefer M, Harke R, Denke C. Open-label placebos improve symptoms in allergic rhinitis: a randomized controlled trial. Psychother Psychosom. 2016;85:373–374.
23. Carvalho C, Caetano JM, Cunha L, et al. Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain. 2016;157:2766–2772.
24. Zhang W, Robertson J, Jones AC, et al. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008;67:1716–1723.
25. Howick J, Friedemann C, Tsakok M, et al. Are treatments more effective than placebos? a systematic review and meta-analysis. PLoS One. 2013;8:e62599.
26. Di Blasi Z, Harkness E, Ernst E, et al. Influence of context effects on health outcomes: a systematic review. Lancet. 2001;357:757–762.
27. McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol. 2014;67:267–277.
28. Saretsky G. The OEO P.C. Experiment and the John Henry effect. Phi Delta Kappan. 1972;53:579–581.
29. Irving G, Holden J. The John Henry effect. BMJ. 2013;346:f1804.
30. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol. 2008;59:565–590.
31. Schafer SM, Colloca L, Wager TD. Conditioned placebo analgesia persists when subjects know they are receiving a placebo. J Pain. 2015;16:412–420.
32. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
33. Friedman R, Sedler M, Myers P, et al. Behavioral medicine, complementary medicine and integrated care. Economic implications. Prim Care. 1997;24:949–962.
34. Caspi O, Bootzin RR. Evaluating how placebos produce change. Logical and causal traps and understanding cognitive explanatory mechanisms. Eval Health Prof. 2002;25:436–464.
35. Annoni M, Miller FG. Placebo effects and the ethics of therapeutic communication: a pragmatic perspective. Kennedy Inst Ethics J. 2016;26:79–103.
36. Shapiro LA, ed. The Routledge Handbook of Embodied Cognition. 1st ed. New York: Routledge, Taylor & Francis Group; 2014.
37. Kemmerer D, Miller L, Macpherson MK, et al. An investigation of semantic similarity judgments about action and non-action verbs in Parkinson's disease: implications for the embodied cognition framework. Front Hum Neurosci. 2013;7:146.
38. Thompson JJ, Ritenbaugh C, Nichter M. Reconsidering the placebo response from a broad anthropological perspective. Cult Med Psychiatry. 2009;33:112–152.
39. Fuchs T, Schlimme JE. Embodiment and psychopathology: a phenomenological perspective. Curr Opin Psychiatry. 2009;22:570–575.
40. Foddy B. A duty to deceive: placebos in clinical practice. Am J Bioeth. 2009;9:4–12.